Login to Your Account

NewCo News

S-TARget Seeking $8M for Allergy Vaccine Platform

By Cormac Sheridan
Staff Writer

Wednesday, April 10, 2013
S-TARget therapeutics GmbH, an Austrian start-up developing therapeutic vaccines for allergies, aims to close a €6 million (US$7.8 million) Series A funding round in the coming months.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription